Vice President, Marketing
Kyverna Therapeutics
Vice President, Marketing
Kyverna Therapeutics
T cell therapies for autoimmune diseases
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Title: Vice President, Marketing
Reports to: Chief Commercial Officer
Location: West Coast Remote
Travel: Approximately 25–40%
Summary
We are seeking an experienced, strategic Vice President, Marketing to lead the development and execution of the company’s commercial marketing strategy as we prepare for and progress through product launch and subsequent indication expansion.
The VP, Marketing will own marketing strategy across the product lifecycle, including launch planning, positioning, segmentation, customer strategy, market development, promotional strategy, and lifecycle expansion across multiple indications. This leader will work closely with Sales, Medical Affairs, Clinical Development, Lifecycle Leadership, Market Access, Regulatory, Commercial Operations and senior leadership to translate clinical and market insights into differentiated commercial strategies for multi-specialty HCPs and patients.
The ideal candidate combines strategic thinking with hands-on execution and has demonstrated success taking innovative therapies from late-stage development through commercialization, leveraging integrated omnichannel strategies to engage HCPs and patients.
The national salary range for this position is $320K to $350K USD annually. The salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock plan.
T cell therapies for autoimmune diseases
Kyverna Therapeutics develops cell therapies for autoimmune diseases. The company uses synthetic biology, immunology, and cell engineering to create engineered T cells designed to target and modulate the root causes of autoimmunity. Its therapies are intended to be given by a single infusion to achieve long-lasting disease control, reducing or eliminating the need for ongoing treatments. Kyverna pursues in-licensing and collaboration opportunities to broaden its technology and capabilities and to advance its therapies toward patients through development and sales to patients and healthcare providers. The core goal is to provide durable, well-tolerated treatments that can offer substantial, long-term relief for people with autoimmune diseases.
Explore more opportunities at Kyverna Therapeutics